1. Home
  2. VRAX vs MBOT Comparison

VRAX vs MBOT Comparison

Compare VRAX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • MBOT
  • Stock Information
  • Founded
  • VRAX 2013
  • MBOT 2010
  • Country
  • VRAX United Kingdom
  • MBOT United States
  • Employees
  • VRAX N/A
  • MBOT N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MBOT Medical/Dental Instruments
  • Sector
  • VRAX Health Care
  • MBOT Health Care
  • Exchange
  • VRAX Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • VRAX 17.2M
  • MBOT 16.7M
  • IPO Year
  • VRAX 2022
  • MBOT N/A
  • Fundamental
  • Price
  • VRAX $1.97
  • MBOT $0.95
  • Analyst Decision
  • VRAX
  • MBOT Strong Buy
  • Analyst Count
  • VRAX 0
  • MBOT 1
  • Target Price
  • VRAX N/A
  • MBOT $7.00
  • AVG Volume (30 Days)
  • VRAX 4.9M
  • MBOT 155.6K
  • Earning Date
  • VRAX 11-26-2024
  • MBOT 11-13-2024
  • Dividend Yield
  • VRAX N/A
  • MBOT N/A
  • EPS Growth
  • VRAX N/A
  • MBOT N/A
  • EPS
  • VRAX N/A
  • MBOT N/A
  • Revenue
  • VRAX $156,419.00
  • MBOT N/A
  • Revenue This Year
  • VRAX $5,169.18
  • MBOT N/A
  • Revenue Next Year
  • VRAX $66.97
  • MBOT N/A
  • P/E Ratio
  • VRAX N/A
  • MBOT N/A
  • Revenue Growth
  • VRAX 1727.11
  • MBOT N/A
  • 52 Week Low
  • VRAX $0.60
  • MBOT $0.82
  • 52 Week High
  • VRAX $9.00
  • MBOT $2.35
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 46.98
  • MBOT 47.00
  • Support Level
  • VRAX $1.92
  • MBOT $0.93
  • Resistance Level
  • VRAX $2.50
  • MBOT $0.99
  • Average True Range (ATR)
  • VRAX 0.22
  • MBOT 0.05
  • MACD
  • VRAX 0.01
  • MBOT 0.00
  • Stochastic Oscillator
  • VRAX 26.97
  • MBOT 26.20

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Share on Social Networks: